Ethics in the Treatment of Advanced Heart Failure: Palliative Care and End-of-Life Issues

24Citations
Citations of this article
80Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Advanced heart failure (HF) is a life-shortening condition, yet there are increasing treatments and implantable devices available to clinicians to manage patients with advanced HF. Planning for adverse events and the end of life, formulated as "preparedness planning," can be integrated into HF care early in illness. Discussions that acknowledge the uncertainty of HF course and length of life and incorporate patient and family goals and values facilitates this planning. Clear processes for weighing potential benefits and burdens of interventions and therapies should accompany decision-making. Device implantation decision-making can acknowledge alternative avenues of care to the device and identify situations in which the device might be deactivated in the future. Symptom assessment and management potentially improve quality of life in patients with advanced HF. Management of symptoms should integrate HF therapies as well as other treatments. Collaboration between HF providers, palliative care clinicians, and, if appropriate, hospice clinicians will improve care for HF patients and their families. © 2011 Wiley Periodicals, Inc.

Cite

CITATION STYLE

APA

Tanner, C. E., Fromme, E. K., & Goodlin, S. J. (2011, September). Ethics in the Treatment of Advanced Heart Failure: Palliative Care and End-of-Life Issues. Congestive Heart Failure. https://doi.org/10.1111/j.1751-7133.2011.00245.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free